| 1 |
34748415 | Effect of Vancomycin on Cellular Fatty Acid Profiles of Vancomycin-Susceptible and Nonsusceptible Staphylococcus aureus. | 2022 Mar |
1 |
| 2 |
31545160 | Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant Staphylococcus aureus. | 2020 Mar |
2 |
| 3 |
32734419 | Etest Methods for Screening Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) strains. | 2020 Oct |
1 |
| 4 |
31670275 | Detection of heterogeneous vancomycin-intermediate Staphylococcus aureus: A preliminary report from south India. | 2019 Aug |
1 |
| 5 |
29555635 | β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA. | 2018 Jun |
3 |
| 6 |
28827421 | Prevalence of Slow-Growth Vancomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureus. | 2017 Nov |
1 |
| 7 |
26915612 | Prevalence and Clinical Impact of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolated From Hospitalized Patients. | 2016 May |
1 |
| 8 |
25982914 | Genotype-specific prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in Asian countries. | 2015 Sep |
1 |
| 9 |
24092658 | Reduced susceptibility to vancomycin in isogenic Staphylococcus aureus strains of sequence type 59: tracking evolution and identifying mutations by whole-genome sequencing. | 2014 Feb |
3 |
| 10 |
27873679 | Vancomycin-intermediate resistance in Staphylococcus aureus. | 2014 Dec |
3 |
| 11 |
23422917 | Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin-resistant vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA. | 2013 May |
1 |
| 12 |
22033576 | Heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) emerged before the clinical introduction of vancomycin in Japan: a retrospective study. | 2012 Jun |
1 |
| 13 |
22064529 | Low prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates among Connecticut veterans. | 2012 Jan |
1 |
| 14 |
24470927 | Screening and detection of heterogenous vancomycin intermediate Staphylococcus aureus in Hospital Kuala Lumpur Malaysia, using the glycopeptide resistance detection Etest and population analysis profiling. | 2012 Jan 2 |
1 |
| 15 |
19369444 | Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years. | 2009 Jun |
2 |
| 16 |
19506056 | Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA. | 2009 Aug |
5 |
| 17 |
15889359 | Low colonization prevalence of Staphylococcus aureus with reduced vancomycin susceptibility among patients undergoing hemodialysis in the San Francisco Bay area. | 2005 Jun 1 |
2 |
| 18 |
11758077 | Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin. | 2001 Nov 5 |
1 |